Search results
Found 22 matches for
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial
Coronavirus COVID-19
Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.
Reflections on gratitude during lockdown
Coronavirus COVID-19 Wellbeing and mental health
Louise King collates our words of gratitude amid the COVID-19 pandemic.